Novartis Pharma Services

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Our mission is to discover new ways to improve and extend people’s lives. Our vision is to be a trusted leader in changing the practice of medicine. Our strategy is to use science-based innovation to deliver better patient outcomes in growing areas of healthcare.
A leading global corporation, Novartis covers a wide range of therapeutical areas, providing innovative patent-protected medicines, over-the-counter products, vaccines as well as affordable high-quality generic medicines or eye care solutions.
Novartis is a global healthcare company based in Basel, Switzerland, with a history going back more than 150 years. We provide healthcare solutions that address the evolving needs of patients and societies worldwide. Novartis products are available in about 155 countries and they reached nearly 1 billion people globally in 2016. About 123 000 people of 142 nationalities work at Novartis around the world.
In 2016, the Group's continuing operations achieved net sales of USD 48,5 billion, while approximately USD 9.0 billion invested in Research and development in 2016, amounting to18.6% of net sales (USD). The Novartis Malaria Initiative achieved another milestone in 2016, having delivered more than 800 million treatments without profit since 2001.
Research and development (R&D) is at the core of our company and central to our strategy. Significant investments are made in research at the intersection of greatest patient need and high scientific promise. The strong development pipeline includes more than 200 projects (as per the 2016 annual report) in clinical development.